Healthcare
Turkven buys Carlyle's stake in Medical Park
Turkish private equity firm Turkven has acquired Carlyle’s 40% stake in hospital chain Medical Park.
VC-backed uniQure files $75m IPO
Dutch gene therapy company uniQure, backed by several venture capital firms, plans on raising up to $75m in its IPO on the Nasdaq.
Imperial increases investment in TopiVert
Imperial Innovations has injected a further ТЃ4.5m into existing portfolio company TopiVert, a UK-based developer of treatments for inflammatory eye and gut diseases.
Enterprise Ireland et al. back Metabolomic
Enterprise Ireland, SOSVentures and the AIB Seed Capital Fund have injected тЌ750,000 into the series-A funding round of Ireland-based Metabolomic Diagnostics.
BGF injects £6m into Medicina
The Business Growth Fund (BGF) has invested ТЃ6m in Bolton-based medical devices company Medicina.
Crescendo Biologics secures £17.5m series-A
UK biotech Crescendo Biologics has raised ТЃ17.5m in its series-A funding round from Imperial Innovations, Astellas Venture Management (AVM) and existing investor Sofinnova Partners.
Deutsche Private Equity buys Zellbios from Ergon
Deutsche Private Equity (DPE) has acquired Luxembourg-based pharmaceuticals firm Zellbios from Ergon Capital Partners.
Forbion et al. back Ario Pharma
Forbion Capital Partners, Seroba Kernel Life Sciences and New Science Ventures (NSV) have injected ТЃ1.9m into UK biotech Ario Pharma.
Bridgepoint Development Capital picks up Quotient
Bridgepoint Development Capital (BDC) has acquired outsourced drug development business Quotient Clinical from Quotient Bioresearch Group.
Seventure et al. back EndoControl
Seventure Partners, CM-CIC Capital Innovation and Viveris Management have injected €4m into EndoControl, a French surgical robotics developer.
Omnes et al. invest €8m in Gecko Biomedical
Omnes Capital, CM-CIC Capital Finance and CapDecisif Management have backed an €8m series-A round for Paris-based medical devices company Gecko Biomedical.
Cinven's Amco in bolt-on
Cinven portfolio company Amdipharm Mercury (Amco) has acquired Abcur, a Swedish pharmaceutical business.
Graphite purchases Sovereign's City & County
Graphite Capital has acquired home care provider City & County Healthcare Group from Sovereign Capital.
Gimv backs Eurocept
Gimv has invested in Eurocept Group, a Dutch provider of medical homecare services and specialised medicines, in exchange for a minority stake.
Duke Street backs Air Products homecare carve-out
Duke Street has backed the management buyout of NYSE-listed Air Products & Chemicals' UK homecare business.
PE still in race for Rexam healthcare unit
Medical supply maker Gerresheimer has dropped out of the bidding process for Rexam's healthcare unit, while private equity firms such as Bain and KKR are still in the race, according to local reports.
Vækstfonden backs Nanovi with €600,000
VУІkstfonden has provided тЌ600,000 in seed capital for Nanovi, a Danish company developing products based on biomaterials for the treatment of cancer.
Telormedix raises $6.6m from Aravis and Proquest
Swiss biopharmaceutical company Telormedix has raised $6.6m in a series-B financing round extension from existing backers Aravis Venture and Proquest Investments.
Deal in focus: MIG backs Ganymed in €45m series-E
MIG Verwaltungs has reinvested in biopharmaceutical company Ganymed Pharmaceuticals in a joint €45m series-E financing round, alongside family office ATS Beteiligungsverwaltung, in what marks the largest biotechnology early-stage investment in the DACH...
Gimv, UI Gestion acquire Almaviva
Gimv and UI Gestion have acquired French operator of private clinics Almaviva Santé from 21 Partners, with each of the firms contributing €40m towards the buyout.
CEA Investissement et al. back Bioaxial
Paris-based medical equipment company Bioaxial has raised €1.9m from CEA Investissement, Viveris Management, Inserm Transfert Initiative (ITI) and several individual investors.
Novartis to offload assets
Swiss pharmaceutical giant Novartis has announced it is open to spinning out non-core assets as part of its strategic review and its plans for a $5bn share buy-back.
Gilde Healthcare closes fund on €145m
Gilde Healthcare Partners has held the final close of its transatlantic life sciences venture fund, Gilde Healthcare III (GHC III), on its target of €145m.
VC-backed Implanet floats
French medical technology company Implanet, backed by several venture capital firms, has listed on the NYSE Euronext Paris with a market cap of €39m.